HEADER HYDROLASE 29-APR-09 3H8C TITLE A COMBINED CRYSTALLOGRAPHIC AND MOLECULAR DYNAMICS STUDY OF CATHEPSIN- TITLE 2 L RETRO-BINDING INHIBITORS (COMPOUND 14) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CATHEPSIN L1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATHEPSIN L HEAVY CHAIN AND LIGHT CHAIN, UNP RESIDUES 114- COMPND 5 333; COMPND 6 SYNONYM: MAJOR EXCRETED PROTEIN, MEP, CATHEPSIN L1 HEAVY CHAIN, COMPND 7 CATHEPSIN L1 LIGHT CHAIN; COMPND 8 EC: 3.4.22.15; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CATHEPSIN L; SOURCE 6 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 7 EXPRESSION_SYSTEM_COMMON: YEAST; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 4932 KEYWDS CYSTEINE PROTEASES, CATHEPSIN L, DISULFIDE BOND, GLYCOPROTEIN, KEYWDS 2 HYDROLASE, LYSOSOME, PROTEASE, THIOL PROTEASE, ZYMOGEN EXPDTA X-RAY DIFFRACTION AUTHOR S.R.TULSIDAS,S.F.CHOWDHURY,S.KUMAR,L.JOSEPH,E.O.PURISIMA,J.SIVARAMAN REVDAT 2 12-NOV-14 3H8C 1 HET HETATM SEQRES VERSN REVDAT 1 20-OCT-09 3H8C 0 JRNL AUTH R.T.SHENOY,S.F.CHOWDHURY,S.KUMAR,L.JOSEPH,E.O.PURISIMA, JRNL AUTH 2 J.SIVARAMAN JRNL TITL A COMBINED CRYSTALLOGRAPHIC AND MOLECULAR DYNAMICS STUDY OF JRNL TITL 2 CATHEPSIN L RETROBINDING INHIBITORS JRNL REF J.MED.CHEM. 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19761244 JRNL DOI 10.1021/JM900596Y REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 15685 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.292 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 914 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3322 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 106 REMARK 3 SOLVENT ATOMS : 129 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.39 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -7.71900 REMARK 3 B22 (A**2) : -1.31500 REMARK 3 B33 (A**2) : 9.03500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 52.34 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3H8C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-JUL-09. REMARK 100 THE RCSB ID CODE IS RCSB052819. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16224 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06700 REMARK 200 FOR THE DATA SET : 17.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.96100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.30800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.50550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 66.30800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.96100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.50550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 175 REMARK 465 GLU A 176 REMARK 465 SER A 177 REMARK 465 ASP A 178 REMARK 465 ASN A 179 REMARK 465 THR B 175 REMARK 465 GLU B 176 REMARK 465 SER B 177 REMARK 465 ASP B 178 REMARK 465 ASN B 179 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 221 O HOH B 242 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 15 174.01 -57.32 REMARK 500 LYS A 117 53.44 -69.47 REMARK 500 PRO A 154 10.16 -67.15 REMARK 500 ARG A 205 53.05 -117.30 REMARK 500 PRO B 2 170.03 -51.61 REMARK 500 TRP B 7 -17.86 -45.85 REMARK 500 CYS B 65 0.51 -67.76 REMARK 500 ALA B 93 27.19 44.04 REMARK 500 ALA B 202 121.53 -36.53 REMARK 500 ARG B 205 54.60 -116.74 REMARK 500 ALA B 214 50.46 -147.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NSZ A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NSZ B 400 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3H89 RELATED DB: PDB REMARK 900 RELATED ID: 3H8B RELATED DB: PDB DBREF 3H8C A 1 220 UNP P07711 CATL1_HUMAN 114 333 DBREF 3H8C B 1 220 UNP P07711 CATL1_HUMAN 114 333 SEQRES 1 A 220 ALA PRO ARG SER VAL ASP TRP ARG GLU LYS GLY TYR VAL SEQRES 2 A 220 THR PRO VAL LYS ASN GLN GLY GLN CYS GLY SER CSD TRP SEQRES 3 A 220 ALA PHE SER ALA THR GLY ALA LEU GLU GLY GLN MET PHE SEQRES 4 A 220 ARG LYS THR GLY ARG LEU ILE SER LEU SER GLU GLN ASN SEQRES 5 A 220 LEU VAL ASP CYS SER GLY PRO GLN GLY ASN GLU GLY CYS SEQRES 6 A 220 ASN GLY GLY LEU MET ASP TYR ALA PHE GLN TYR VAL GLN SEQRES 7 A 220 ASP ASN GLY GLY LEU ASP SER GLU GLU SER TYR PRO TYR SEQRES 8 A 220 GLU ALA THR GLU GLU SER CYS LYS TYR ASN PRO LYS TYR SEQRES 9 A 220 SER VAL ALA ASN ASP THR GLY PHE VAL ASP ILE PRO LYS SEQRES 10 A 220 GLN GLU LYS ALA LEU MET LYS ALA VAL ALA THR VAL GLY SEQRES 11 A 220 PRO ILE SER VAL ALA ILE ASP ALA GLY HIS GLU SER PHE SEQRES 12 A 220 LEU PHE TYR LYS GLU GLY ILE TYR PHE GLU PRO ASP CYS SEQRES 13 A 220 SER SER GLU ASP MET ASP HIS GLY VAL LEU VAL VAL GLY SEQRES 14 A 220 TYR GLY PHE GLU SER THR GLU SER ASP ASN ASN LYS TYR SEQRES 15 A 220 TRP LEU VAL LYS ASN SER TRP GLY GLU GLU TRP GLY MET SEQRES 16 A 220 GLY GLY TYR VAL LYS MET ALA LYS ASP ARG ARG ASN HIS SEQRES 17 A 220 CYS GLY ILE ALA SER ALA ALA SER TYR PRO THR VAL SEQRES 1 B 220 ALA PRO ARG SER VAL ASP TRP ARG GLU LYS GLY TYR VAL SEQRES 2 B 220 THR PRO VAL LYS ASN GLN GLY GLN CYS GLY SER CSD TRP SEQRES 3 B 220 ALA PHE SER ALA THR GLY ALA LEU GLU GLY GLN MET PHE SEQRES 4 B 220 ARG LYS THR GLY ARG LEU ILE SER LEU SER GLU GLN ASN SEQRES 5 B 220 LEU VAL ASP CYS SER GLY PRO GLN GLY ASN GLU GLY CYS SEQRES 6 B 220 ASN GLY GLY LEU MET ASP TYR ALA PHE GLN TYR VAL GLN SEQRES 7 B 220 ASP ASN GLY GLY LEU ASP SER GLU GLU SER TYR PRO TYR SEQRES 8 B 220 GLU ALA THR GLU GLU SER CYS LYS TYR ASN PRO LYS TYR SEQRES 9 B 220 SER VAL ALA ASN ASP THR GLY PHE VAL ASP ILE PRO LYS SEQRES 10 B 220 GLN GLU LYS ALA LEU MET LYS ALA VAL ALA THR VAL GLY SEQRES 11 B 220 PRO ILE SER VAL ALA ILE ASP ALA GLY HIS GLU SER PHE SEQRES 12 B 220 LEU PHE TYR LYS GLU GLY ILE TYR PHE GLU PRO ASP CYS SEQRES 13 B 220 SER SER GLU ASP MET ASP HIS GLY VAL LEU VAL VAL GLY SEQRES 14 B 220 TYR GLY PHE GLU SER THR GLU SER ASP ASN ASN LYS TYR SEQRES 15 B 220 TRP LEU VAL LYS ASN SER TRP GLY GLU GLU TRP GLY MET SEQRES 16 B 220 GLY GLY TYR VAL LYS MET ALA LYS ASP ARG ARG ASN HIS SEQRES 17 B 220 CYS GLY ILE ALA SER ALA ALA SER TYR PRO THR VAL MODRES 3H8C CSD A 25 CYS 3-SULFINOALANINE MODRES 3H8C CSD B 25 CYS 3-SULFINOALANINE HET CSD A 25 8 HET CSD B 25 8 HET NSZ A 300 53 HET NSZ B 400 53 HETNAM CSD 3-SULFINOALANINE HETNAM NSZ N-(BIPHENYL-4-YLACETYL)-S-METHYL-L-CYSTEINYL-D-ARGINYL- HETNAM 2 NSZ N-(2-PHENYLETHYL)-L-PHENYLALANINAMIDE HETSYN CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE FORMUL 1 CSD 2(C3 H7 N O4 S) FORMUL 3 NSZ 2(C41 H49 N7 O4 S) FORMUL 5 HOH *129(H2 O) HELIX 1 1 ARG A 8 GLY A 11 5 4 HELIX 2 2 SER A 24 GLY A 43 1 20 HELIX 3 3 SER A 49 SER A 57 1 9 HELIX 4 4 GLU A 63 GLY A 67 5 5 HELIX 5 5 LEU A 69 ASN A 80 1 12 HELIX 6 6 ASN A 101 LYS A 103 5 3 HELIX 7 7 GLN A 118 VAL A 129 1 12 HELIX 8 8 HIS A 140 PHE A 145 1 6 HELIX 9 9 ASN A 207 ILE A 211 5 5 HELIX 10 10 ARG B 8 GLY B 11 5 4 HELIX 11 11 SER B 24 GLY B 43 1 20 HELIX 12 12 SER B 49 SER B 57 1 9 HELIX 13 13 GLU B 63 GLY B 67 5 5 HELIX 14 14 LEU B 69 GLY B 81 1 13 HELIX 15 15 GLN B 118 VAL B 129 1 12 HELIX 16 16 HIS B 140 PHE B 145 1 6 HELIX 17 17 ASN B 207 ILE B 211 5 5 SHEET 1 A 3 VAL A 5 ASP A 6 0 SHEET 2 A 3 HIS A 163 PHE A 172 -1 O TYR A 170 N VAL A 5 SHEET 3 A 3 ILE A 132 ILE A 136 -1 N VAL A 134 O VAL A 165 SHEET 1 B 5 VAL A 5 ASP A 6 0 SHEET 2 B 5 HIS A 163 PHE A 172 -1 O TYR A 170 N VAL A 5 SHEET 3 B 5 LYS A 181 LYS A 186 -1 O LYS A 186 N LEU A 166 SHEET 4 B 5 TYR A 198 ALA A 202 -1 O VAL A 199 N VAL A 185 SHEET 5 B 5 ILE A 150 TYR A 151 1 N TYR A 151 O LYS A 200 SHEET 1 C 2 LEU A 83 ASP A 84 0 SHEET 2 C 2 SER A 105 ALA A 107 -1 O VAL A 106 N LEU A 83 SHEET 1 D 2 PHE A 112 ASP A 114 0 SHEET 2 D 2 SER A 216 PRO A 218 -1 O TYR A 217 N VAL A 113 SHEET 1 E 3 VAL B 5 ASP B 6 0 SHEET 2 E 3 HIS B 163 PHE B 172 -1 O TYR B 170 N VAL B 5 SHEET 3 E 3 ILE B 132 ILE B 136 -1 N VAL B 134 O VAL B 165 SHEET 1 F 5 VAL B 5 ASP B 6 0 SHEET 2 F 5 HIS B 163 PHE B 172 -1 O TYR B 170 N VAL B 5 SHEET 3 F 5 LYS B 181 LYS B 186 -1 O LYS B 186 N LEU B 166 SHEET 4 F 5 TYR B 198 ALA B 202 -1 O MET B 201 N TRP B 183 SHEET 5 F 5 ILE B 150 TYR B 151 1 N TYR B 151 O LYS B 200 SHEET 1 G 2 PHE B 112 ASP B 114 0 SHEET 2 G 2 SER B 216 PRO B 218 -1 O TYR B 217 N VAL B 113 SSBOND 1 CYS A 22 CYS A 65 1555 1555 2.03 SSBOND 2 CYS A 56 CYS A 98 1555 1555 2.04 SSBOND 3 CYS A 156 CYS A 209 1555 1555 2.04 SSBOND 4 CYS B 22 CYS B 65 1555 1555 2.03 SSBOND 5 CYS B 56 CYS B 98 1555 1555 2.04 SSBOND 6 CYS B 156 CYS B 209 1555 1555 2.03 LINK C SER A 24 N CSD A 25 1555 1555 1.33 LINK C CSD A 25 N TRP A 26 1555 1555 1.33 LINK C SER B 24 N CSD B 25 1555 1555 1.32 LINK C CSD B 25 N TRP B 26 1555 1555 1.33 SITE 1 AC1 23 ARG A 8 GLU A 9 LYS A 10 GLY A 11 SITE 2 AC1 23 ASN A 18 GLN A 19 GLY A 20 CYS A 22 SITE 3 AC1 23 CSD A 25 GLY A 61 GLU A 63 ASN A 66 SITE 4 AC1 23 GLY A 67 GLY A 68 LEU A 69 MET A 70 SITE 5 AC1 23 ALA A 135 ALA A 138 MET A 161 ASP A 162 SITE 6 AC1 23 HOH A 221 HOH A 259 PHE B 145 SITE 1 AC2 23 PHE A 145 ARG B 8 GLU B 9 LYS B 10 SITE 2 AC2 23 GLY B 11 ASN B 18 GLN B 19 GLY B 20 SITE 3 AC2 23 CYS B 22 CSD B 25 GLU B 63 ASN B 66 SITE 4 AC2 23 GLY B 67 GLY B 68 LEU B 69 MET B 70 SITE 5 AC2 23 ALA B 135 ALA B 138 GLY B 139 ASP B 162 SITE 6 AC2 23 TRP B 189 HOH B 257 HOH B 266 CRYST1 57.922 59.011 132.616 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017265 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016946 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007541 0.00000